Design Therapeutics, Inc.

NASDAQ:DSGN

Biotechnology

Healthcare
$9.84 +1.59%

+$0.19 today

Market cap
$630.12M
Beta
1.66
P/E (TTM)
-10.7
EPS (TTM)
-$1.13
52W Low $3.33High $17.25

Volume 0.29M

Average 0.74M

Private 5-step workspace

Build a DSGN investment thesis

Turn Design Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.